Ventricular septal defect

Ventricular septal defects account for up to 40% of all congenital cardiac malformations. The diagnosis encompasses a broad range of anomalies, including isolated defects and those associated with other congenital cardiac malformations. Presentation, symptoms, natural history, and management of ventricular septal defects depend on size and anatomical associations of the anomaly, patient's age, and local diagnostic and interventional expertise. In this Seminar, we describe the anatomical range of ventricular septal defects and discuss present management of these malformations. Genetic determinants, diagnostic techniques, physiological considerations, and management challenges are examined in detail. Unfortunately, in many circumstances, evidence on which to guide optimum management is scarce. We present some longer term considerations of ventricular septal defects in adolescents and adults, with particular emphasis on patients with raised pulmonary vascular resistance and Eisenmenger's syndrome.

[1]  N. Ayres,et al.  Intraoperative transesophageal echocardiography in congenital heart surgery. The Texas Children's Hospital experience. , 1996, Texas Heart Institute journal.

[2]  Qi-wen Zhou,et al.  The unidirectional valve patch provides no benefits to early and long-term survival in patients with ventricular septal defect and severe pulmonary artery hypertension. , 2010, Journal of Thoracic and Cardiovascular Surgery.

[3]  Z. Du,et al.  High prevalence of muscular ventricular septal defect in neonates. , 1995, Journal of the American College of Cardiology.

[4]  A. Redington,et al.  Measured versus estimated oxygen consumption in ventilated patients with congenital heart disease: The validity of predictive equations , 2003, Critical care medicine.

[5]  D. Penny,et al.  Transcatheter closure of perimembranous ventricular septal defect , 2007, Heart.

[6]  M. Campbell Natural history of ventricular septal defect. , 1971, British heart journal.

[7]  M. Šamánek,et al.  Congenital Heart Disease Among 815,569 Children Born Between 1980 and 1990 and Their 15-Year Survival: A Prospective Bohemia Survival Study , 1999, Pediatric Cardiology.

[8]  E. Bacha,et al.  Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. , 2003, The Journal of thoracic and cardiovascular surgery.

[9]  J. Tweddell,et al.  Ventricular septal defect and aortic valve regurgitation: pathophysiology and indications for surgery. , 2006, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[10]  T. Geva,et al.  Quantitation of echocardiographic predictors of outcome in infants with isolated ventricular septal defect. , 1995, American heart journal.

[11]  R. Hetzer,et al.  Initial clinical manifestations and mid- and long-term results after surgical repair of double-chambered right ventricle in children and adults , 2008, Cardiology in the Young.

[12]  J. Lock,et al.  Transcatheter closure of high‐risk muscular ventricular septal defects with the CardioSEAL occluder: Initial report from the CardioSEAL VSD Registry , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  L. Benson,et al.  Late complete heart block in an adult patient undergoing percutaneous ventricular septal defect closure. , 2008, The Journal of invasive cardiology.

[14]  B. Griffith,et al.  Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction: effect of cyclosporine. , 1992, The Journal of Heart and Lung Transplantation.

[15]  A. Herman,et al.  Indications for tricuspid valve detachment in closure of ventricular septal defect in children. , 2006, The Annals of thoracic surgery.

[16]  J. Wilkinson,et al.  Ventricular septal defect in children born in Liverpool 1960 to 1969. Evaluation of natural course and surgical implications in an unselected population. , 1981, British heart journal.

[17]  A. Branzi,et al.  Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger’s Syndrome , 2012, Drugs.

[18]  N. Nanda,et al.  Real Time Three‐Dimensional Echocardiography in Assessing Ventricular Septal Defects: An Echocardiographic‐Surgical Correlative Study , 2006, Echocardiography.

[19]  M. Gatzoulis,et al.  Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. , 2008, International journal of cardiology.

[20]  R. Arnold,et al.  Epidemiology of congenital heart disease in Merseyside—1979 to 1988 , 1996, Cardiology in the Young.

[21]  D. Mcnamara,et al.  Congenital heart disease in twins. , 1967, The New England journal of medicine.

[22]  A. Bogers,et al.  Long-term follow-up and quality of life after closure of ventricular septal defect in adults. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  Philipp Beerbaum,et al.  Noninvasive Quantification of Left-to-Right Shunt in Pediatric Patients: Phase-Contrast Cine Magnetic Resonance Imaging Compared With Invasive Oximetry , 2001, Circulation.

[24]  J. Fasules,et al.  Pulmonary hypertension and arterial changes in calves with a systemic-to-left pulmonary artery connection. , 1994, Journal of applied physiology.

[25]  P. Beerbaum,et al.  Adult congenital heart disease – Double-chambered right ventricle , 2007, Clinical Research in Cardiology.

[26]  J. Sandoval,et al.  Advanced pulmonary vascular disease: the Eisenmenger syndrome , 2009, Cardiology in the Young.

[27]  B. Thanopoulos,et al.  Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. , 1999, Journal of the American College of Cardiology.

[28]  P. Wood,et al.  VENTRICULAR SEPTAL DEFECT WITH A NOTE ON ACYANOTIC FALLOT'S TETRALOGY , 1954, British heart journal.

[29]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[30]  R. Moreno-Rodriguez,et al.  Embryological Development of the Apical Trabeculated Region of Both Ventricles. The Contribution of the Primitive Interventricular Septum in the Ventricular Septation , 1998 .

[31]  J. Rychik,et al.  Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: report from the task force of the Pediatric Council of the American Society of Echocardiography. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  C. Brizard,et al.  Initial results of primary device closure of large muscular ventricular septal defects in early infancy using perventricular access , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[33]  T. Spray,et al.  Predictive value of intraoperative diagnosis of residual ventricular septal defects by transesophageal echocardiography. , 2010, The Annals of thoracic surgery.

[34]  J. Nora,et al.  Multifactorial Inheritance Hypothesis for the Etiology of Congenital Heart Diseases: The Genetic‐Environmental Interaction , 1968, Circulation.

[35]  Larry M Baddour,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card , 2007, Circulation.

[36]  J. Hoffman,et al.  Incidence of congenital heart disease: I. Postnatal incidence , 1995, Pediatric Cardiology.

[37]  David I. Wilson,et al.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family , 1997, Nature Genetics.

[38]  A. Limsuwan,et al.  Aerosolized iloprost for pulmonary vasoreactivity testing in children with long‐standing pulmonary hypertension related to congenital heart disease , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[39]  B. Bruneau The developmental genetics of congenital heart disease , 2008, Nature.

[40]  C. Mavroudis,et al.  Congenital Heart Surgery Nomenclature and Database Project: ventricular septal defect. , 2000, The Annals of thoracic surgery.

[41]  R O Bonow,et al.  Current Diagnostic Techniques of Assessing Myocardial Viabilit in Patients With Hibernating and Stunned Myocardium , 1993, Circulation.

[42]  M. Tofeig,et al.  Transcatheter closure of a mid-muscular ventricular septal defect with an Amplatzer VSD occluder device , 1999, Heart.

[43]  P. Poole‐Wilson,et al.  Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication , 2005, Circulation.

[44]  S. Zaffran,et al.  Genetics and embryological mechanisms of congenital heart diseases. , 2009, Archives of cardiovascular diseases.

[45]  W. Gersony,et al.  Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. , 2007, The Journal of pediatrics.

[46]  Helmut Baumgartner,et al.  Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. , 2002, Journal of the American College of Cardiology.

[47]  A. Eroğlu,et al.  Evolution of Ventricular Septal Defect with Special Reference to Spontaneous Closure Rate, Subaortic Ridge and Aortic Valve Prolapse , 2002, Pediatric Cardiology.

[48]  T. Miyamoto,et al.  Double chambered right ventricle: depiction at three-dimensional whole heart magnetic resonance imaging. , 2007, International journal of cardiology.

[49]  G. Diller,et al.  Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension , 2008, Circulation.

[50]  A. Contreras-Ramos,et al.  Normal Development of the Muscular Region of the Interventricular Septum – I. The Significance of the Ventricular Trabeculations , 2008, Anatomia, histologia, embryologia.

[51]  J. Cheatham,et al.  Ventricular septal defect in infancy: detection with two dimensional echocardiography. , 1981, The American journal of cardiology.

[52]  N. Ammash,et al.  Cerebrovascular events in adult patients with cyanotic congenital heart disease. , 1996, Journal of the American College of Cardiology.

[53]  D. Moodie,et al.  Difficulty in diagnosing double-chambered right ventricle in adults. , 2001, The American journal of cardiology.

[54]  Philipp Beerbaum,et al.  Flow Volume and Shunt Quantification in Pediatric Congenital Heart Disease by Real-Time Magnetic Resonance Velocity Mapping: A Validation Study , 2004, Circulation.

[55]  M. Rabinovitch Pulmonary hypertension: pathophysiology as a basis for clinical decision making. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[56]  N. Fine,et al.  Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review. , 2009, The Canadian journal of cardiology.

[57]  S. Wort Sildenafil in Eisenmenger syndrome: safety first. , 2007, International journal of cardiology.

[58]  D. Bonnet,et al.  A new strategy for the surgical treatment of aortic coarctation associated with ventricular septal defect in infants using an absorbable pulmonary artery band. , 1999, Journal of the American College of Cardiology.

[59]  M. de Pauw,et al.  The Belgian Eisenmenger syndrome registry: Implications for treatment strategies? , 2009, Acta cardiologica.

[60]  B. Eyskens,et al.  Dilatable pulmonary artery banding in infants with low birth weight or complex congenital heart disease allows avoidance or postponement of subsequent surgery. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[61]  R. Franklin,et al.  Localisation of ventricular septal defects by simultaneous display of superimposed colour Doppler and cross sectional echocardiographic images. , 1985, British heart journal.

[62]  T. Newman Etiology of ventricular septal defects: an epidemiologic approach. , 1985, Pediatrics.

[63]  R. P. Grant The Embryology of Ventricular Flow Pathways in Man , 1962, Circulation.

[64]  R. Markwald,et al.  Living Morphogenesis of the Heart , 1998, Cardiovascular Molecular Morphogenesis.

[65]  Robert H. Anderson,et al.  Classification of ventricular septal defects. , 1980, British heart journal.

[66]  Deepak Srivastava,et al.  Genetic regulation of cardiogenesis and congenital heart disease. , 2006, Annual review of pathology.

[67]  A. Redington,et al.  Primary transcatheter umbrella closure of perimembranous ventricular septal defect. , 1994, British heart journal.

[68]  N. Sandoval,et al.  Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. , 2005, The Annals of thoracic surgery.

[69]  K. Hung,et al.  Spontaneous closure of ventricular septal defects in the first year of life. , 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.

[70]  G. Diller,et al.  Pulmonary Vascular Disease in Adults With Congenital Heart Disease , 2007, Circulation.

[71]  Vivek Muthurangu,et al.  Novel Method of Quantifying Pulmonary Vascular Resistance by Use of Simultaneous Invasive Pressure Monitoring and Phase-Contrast Magnetic Resonance Flow , 2004, Circulation.

[72]  G. Vick Recent advances in pediatric cardiovascular MRI. , 2003, Current opinion in pediatrics.

[73]  H. Boyd,et al.  Recurrence of Congenital Heart Defects in Families , 2009, Circulation.

[74]  M. Gatzoulis,et al.  Clinical update: cyanotic adult congenital heart disease , 2007, The Lancet.

[75]  M. Leval,et al.  Ventricular septal defects , 1968 .

[76]  J. Reid,et al.  Doppler assessment of the interventricular pressure drop in patients with ventricular septal defects. , 1988, British heart journal.

[77]  G. Sutherland,et al.  Ventricular septal defects. Two dimensional echocardiographic and morphological correlations. , 1982, British heart journal.

[78]  E. Tay,et al.  Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy. , 2011, International journal of cardiology.

[79]  Karl W Broman,et al.  Spectrum of heart disease associated with murine and human GATA4 mutation. , 2007, Journal of molecular and cellular cardiology.

[80]  D. Benson Genetic Origins of Pediatric Heart Disease , 2010, Pediatric Cardiology.

[81]  A. Mehta,et al.  Successful percutaneous balloon valvuloplasty of the aortic valve in an infant , 2005, Pediatric Cardiology.

[82]  B. Mulder,et al.  Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? , 2007, American heart journal.

[83]  P. Vernant,et al.  Natural history of ventricular septal defect. A study involving 790 cases. , 1977, Circulation.

[84]  N. Silverman,et al.  The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. , 1998 .

[85]  Deepak Srivastava,et al.  A genetic blueprint for cardiac development , 2000, Nature.

[86]  D. Srivastava,et al.  Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. , 2009, Developmental biology.

[87]  R. Jonas Congenital heart surgery in developing countries. , 2008, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[88]  F. Sennhauser,et al.  Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants , 2008, Journal of perinatal medicine.

[89]  S. Siu,et al.  Choosing the best contraceptive method for the adult with congenital heart disease , 2009, Current cardiology reports.

[90]  S. Hunter,et al.  Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure , 2002, Cardiology in the Young.

[91]  H. Mcintosh Indications for coronary arteriography. , 1977, Circulation.

[92]  Tao Li,et al.  GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease. , 2009, Chinese medical journal.

[93]  M. Beghetti,et al.  Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[94]  R. Axt‐Fliedner,et al.  Isolated ventricular septal defects detected by color Doppler imaging: evolution during fetal and first year of postnatal life , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[95]  J. Hoffman,et al.  Prevalence of congenital heart disease. , 2004, American heart journal.

[96]  D. Lewis,et al.  Descriptive epidemiology of membranous and muscular ventricular septal defects in the Baltimore-Washington Infant Study , 1996, Cardiology in the Young.

[97]  Jeffrey A. Feinstein,et al.  Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young , 2007, Circulation.

[98]  A. Parkhomenko,et al.  Management of grown up congenital heart disease. , 2003, European heart journal.

[99]  J. Edwards,et al.  The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.

[100]  K. Dimopoulos,et al.  Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension , 2010, Circulation.

[101]  R. Kucherlapati,et al.  Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome , 1997, Nature Genetics.

[102]  Jonathan C. Cohen,et al.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 , 2003, Nature.

[103]  B. Wilcox,et al.  The Surgical Anatomy of Ventricular Septal Defect , 1992, Journal of cardiac surgery.

[104]  Eva K. Lee,et al.  Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects. , 2008, Texas Heart Institute journal.

[105]  S. Ho,et al.  The nature of the obstructive muscular bundles in double-chambered right ventricle. , 1999, The Journal of thoracic and cardiovascular surgery.

[106]  Julien I E Hoffman,et al.  Prevalence of congenital heart disease. , 2004, American heart journal.

[107]  K. Dimopoulos,et al.  Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? , 2008, European heart journal.

[108]  Ralf Minkenberg,et al.  Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy. , 2006, The Annals of thoracic surgery.

[109]  Juerg Schwitter,et al.  Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology , 2010, European heart journal.

[110]  K. Dimopoulos,et al.  Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. , 2008, International journal of cardiology.

[111]  M. Gatzoulis,et al.  Bosentan Therapy in Patients With Eisenmenger Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study , 2006, Circulation.

[112]  W. Williams,et al.  An echocardiographic study of the association of ventricular septal defect and right ventricular muscle bundles with a fixed subaortic abnormality. , 1988, The American journal of cardiology.

[113]  Xiaofeng Li,et al.  GATA4 mutations in 486 Chinese patients with congenital heart disease. , 2008, European journal of medical genetics.

[114]  Yali Hou,et al.  Progressive dysfunction of nitric oxide synthase in a lamb model of chronically increased pulmonary blood flow: a role for oxidative stress. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[115]  J. Rychik,et al.  Illustration of the additional value of real-time 3-dimensional echocardiography to conventional transthoracic and transesophageal 2-dimensional echocardiography in imaging muscular ventricular septal defects: does this have any impact on individual patient treatment? , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[116]  C. Lillehei,et al.  The development of the interventricular septum of the human heart; correlative morphogenetic study. , 1970, Chest.

[117]  B. Siassi,et al.  Fetal echocardiography. VII. Doppler color flow mapping: a new technique for the diagnosis of congenital heart disease. , 1987, American journal of obstetrics and gynecology.

[118]  D. Danford,et al.  Color Doppler detection of multiple ventricular septal defects. , 1986, Circulation.

[119]  P. Engelfriet,et al.  Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. , 2007, International journal of cardiology.

[120]  S. Rogers,et al.  Prevention of infective endocarditis' , 1988, British Dental Journal.

[121]  D. Srivastava,et al.  Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. , 2007, Circulation.

[122]  R. Rowe,et al.  Natural history of ventricular septal defect with right-sided aortic arch1 , 1970, British heart journal.

[123]  L. Shekerdemian,et al.  Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. , 2006, American journal of respiratory and critical care medicine.

[124]  S. Goland,et al.  Favorable Outcome of Pregnancy with an Elective Use of Epoprostenol and Sildenafil in Women with Severe Pulmonary Hypertension , 2010, Cardiology.

[125]  E. Villain Indications for Pacing in Patients with Congenital Heart Disease , 2008, Pacing and clinical electrophysiology : PACE.

[126]  W. Cleland Ventricular septal defects. , 1965, Acta chirurgica Scandinavica. Supplementum.

[127]  B. Soto,et al.  Ventricular septal defects: a surgical viewpoint. , 1989, Journal of the American College of Cardiology.

[128]  A. Rudolph Circulatory adjustments after birth: effects on ventricular septal defect , 1971, British heart journal.

[129]  J I Hoffman,et al.  Congenital heart disease in a cohort of 19,502 births with long-term follow-up. , 1978, The American journal of cardiology.

[130]  C. Ramaciotti,et al.  Spatial relationship between the ventricular septal defect and the anomalous muscle bundle in a double-chambered right ventricle. , 2007, Congenital heart disease.

[131]  C. Fraser,et al.  Current expectations for surgical repair of isolated ventricular septal defects. , 2010, The Annals of thoracic surgery.

[132]  T. Geva,et al.  Ventricular septal defects: how shall we describe, name and classify them? , 1989, Journal of the American College of Cardiology.

[133]  J. Edwards,et al.  Graded Pulmonary Vascular Changes and Hemodynamic Findings in Cases of Atrial and Ventricular Septal Defect and Patent Ductus Arteriosus , 1958, Circulation.